Setria® Glutathione Now Available in Australia

Therapeutics Goods Administration approves Setria® Glutathione

Setria® Glutathione is now available after Australia’s Therapeutics Goods Administration (TGA) approved it for use “as a therapeutically active ingredient in adults.” Glutathione was approved and listed within the Therapeutic Goods (Listing) Notice 2014 (No. 5) - F2014L01277

Kyowa Hakko’s Setria® Glutathione will be exclusivity distributed in Australia by Trans Chem, a biotech specialist that sources and imports fine chemicals to Australian manufacturers. TGA approval of Setria® Glutathione was received in October, after a milestone clinical trial of the master antioxidant showed positive results, which were published in the European Journal of Nutrition. Setria® meets the current United States Pharmacopeial (USP) Convention Standards and is available as a dietary supplement in the United States, Canada, Mexico, and select countries in Europe and Asia.

Glutathione is a powerful and natural antioxidant that is obtained two ways: from the food and as part of the body’s internal production. For many reasons including age, health conditions, lifestyle, environment, and certain medications, the body’s stores of Glutathione may be in shorty supply.

Kyowa Hakko uses a patented fermentation technology to manufacture a pure form of Setria® Glutathione. Called nature’s “master antioxidant,” Setria® glutathione replenishes the body’s stores helping to protect cells from oxidative stress and harmful toxins associated with free radicals.

About Trans Chem
Trans Chem is Australia’s leading independent importer and distributor of raw materials to the pharmaceutical, nutraceutical, stock feed and veterinary markets. Operating since 1994, the head office and warehouse is located within the biotech centre of Sydney, with additional facilities in the other major markets of Brisbane and Melbourne. Trans Chem reach extends to over 90% of the Australian market. For more information, visit

About Setria Glutathione
Setria® Glutathione, manufactured by KYOWA HAKKO BIO CO., LTD., is a clinically studied form of glutathione that, when taken orally1, has been shown to replenish the body's reserves, which may be depleted as a result of poor lifestyle choices, stress or natural aging. Called the "master antioxidant," glutathione helps protect cells in the body from the damaging effects of oxidative stress and toxins. Setria glutathione is manufactured through a patented fermentation and patent pending for increasing natural killer (NK) cell activity, is pure, vegetarian and allergen-free. For more information about Setria glutathione, visit

1 Richie JP Jr, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, Schell TD, Muscat JE. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition. May 2014: 1436-6207. doi: 10.1007/s00394-014-0706-z

About Kyowa Hakko USA 
KYOWA HAKKO U.S.A., INC. is the North American sales office for KYOWA HAKKO BIO CO., LTD., an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Lumistor® L-Hydroxyproline, Pantesin® Pantethine, Setria® Glutathione, as well as Sustamine® L-Alanyl-L-Glutamine. For more information visit

Return to News »